Understanding the factors involved in determining the bioburdens of surgical masks

Surgical site infection (SSI) continues to be one of the most common postoperative complications; it is associated with significantly increased morbidity and mortality, prolonged hospital stays, and added costs, all of which cause substantial clinical and economic burdens (1-3). Determining effective strategies to prevent and/or control SSI is therefore vital